label: Introduction of Axicabtagene Ciloleucel Immunotherapy into Central Vein, Percutaneous Approach, New Technology Group 7
label_lc: introduction of axicabtagene ciloleucel immunotherapy into central vein, percutaneous approach, new technology group 7